-
1
-
-
80054872790
-
Alcoholic liver disease: pathogenesis and new therapeutic targets
-
Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141:1572-1582.
-
(2011)
Gastroenterology
, vol.141
, pp. 1572-1582
-
-
Gao, B.1
Bataller, R.2
-
3
-
-
12744267799
-
Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha
-
Crabb D.W., Galli A., Fischer M., You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 2004, 34:35-38.
-
(2004)
Alcohol
, vol.34
, pp. 35-38
-
-
Crabb, D.W.1
Galli, A.2
Fischer, M.3
You, M.4
-
4
-
-
42049113608
-
Involvement of mammalian sirtuin 1 in the action of ethanol in the liver
-
You M., Liang X., Ajmo J.M., Ness G.C. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am. J. Physiol. Gastrointest. Liver. Physiol. 2008, 294:G892-G898.
-
(2008)
Am. J. Physiol. Gastrointest. Liver. Physiol.
, vol.294
, pp. G892-G898
-
-
You, M.1
Liang, X.2
Ajmo, J.M.3
Ness, G.C.4
-
5
-
-
79952227694
-
Nuclear receptors in liver disease
-
Wagner M., Zollner G., Trauner M. Nuclear receptors in liver disease. Hepatology 2011, 53:1023-1034.
-
(2011)
Hepatology
, vol.53
, pp. 1023-1034
-
-
Wagner, M.1
Zollner, G.2
Trauner, M.3
-
6
-
-
80054770307
-
Pathways of liver injury in alcoholic liver disease
-
Tilg H., Moschen A.R., Kaneider N.C. Pathways of liver injury in alcoholic liver disease. J. Hepatol. 2011, 55:1159-1161.
-
(2011)
J. Hepatol.
, vol.55
, pp. 1159-1161
-
-
Tilg, H.1
Moschen, A.R.2
Kaneider, N.C.3
-
7
-
-
84879283106
-
Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases
-
Monsalve F.A., Pyarasani R.D., Delgado-Lopez F., Moore-Carrasco R. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediat. Inflamm. 2013, 2013:1-18.
-
(2013)
Mediat. Inflamm.
, vol.2013
, pp. 1-18
-
-
Monsalve, F.A.1
Pyarasani, R.D.2
Delgado-Lopez, F.3
Moore-Carrasco, R.4
-
8
-
-
84891702448
-
PPAR-α as a key nutritional and environmental sensor for metabolic adaptation
-
Contreras A.V., Torres N., Tovar A.R. PPAR-α as a key nutritional and environmental sensor for metabolic adaptation. Adv. Nutr. 2013, 4:439-452.
-
(2013)
Adv. Nutr.
, vol.4
, pp. 439-452
-
-
Contreras, A.V.1
Torres, N.2
Tovar, A.R.3
-
9
-
-
0000548749
-
Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
-
Pineda Torra I., Gervois P., Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 1999, 10:151-159.
-
(1999)
Curr. Opin. Lipidol.
, vol.10
, pp. 151-159
-
-
Pineda Torra, I.1
Gervois, P.2
Staels, B.3
-
10
-
-
80053185929
-
Fenofibrate: a review of its use in dyslipidaemia
-
McKeage K., Keating G.M. Fenofibrate: a review of its use in dyslipidaemia. Drugs 2011, 71:1917-1946.
-
(2011)
Drugs
, vol.71
, pp. 1917-1946
-
-
McKeage, K.1
Keating, G.M.2
-
11
-
-
33646393509
-
Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance
-
Okopień B., Krysiak R., Herman Z.S. Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance. J. Clin. Endocrinol. Metab. 2006, 91:1770-1778.
-
(2006)
J. Clin. Endocrinol. Metab.
, vol.91
, pp. 1770-1778
-
-
Okopień, B.1
Krysiak, R.2
Herman, Z.S.3
-
12
-
-
84878218164
-
Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress
-
Chan S.M., Sun R.Q., Zeng X.Y., Choong Z.H., Wang H., Watt M.J., Ye J.M. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 2013, 62:2095-2105.
-
(2013)
Diabetes
, vol.62
, pp. 2095-2105
-
-
Chan, S.M.1
Sun, R.Q.2
Zeng, X.Y.3
Choong, Z.H.4
Wang, H.5
Watt, M.J.6
Ye, J.M.7
-
13
-
-
70349260288
-
Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner
-
Chanda D., Lee C.H., Kim Y.H., Nor J.R., Kim D.K., Park J.H., Hwang J.H., Lee M.R., Jeong K.H., Lee I.K., Kweon G.R., Shong M., Oh G.T., Chiang J.Y., Choi H.S. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner. Hepatology 2009, 50:880-892.
-
(2009)
Hepatology
, vol.50
, pp. 880-892
-
-
Chanda, D.1
Lee, C.H.2
Kim, Y.H.3
Nor, J.R.4
Kim, D.K.5
Park, J.H.6
Hwang, J.H.7
Lee, M.R.8
Jeong, K.H.9
Lee, I.K.10
Kweon, G.R.11
Shong, M.12
Oh, G.T.13
Chiang, J.Y.14
Choi, H.S.15
-
14
-
-
79551581810
-
Functional modulation of AMP-activated protein kinase by cereblon
-
Lee K.M., Jo S., Kim H., Lee J., Park C.S. Functional modulation of AMP-activated protein kinase by cereblon. Biochim. Biophys. Acta 2011, 1813:448-455.
-
(2011)
Biochim. Biophys. Acta
, vol.1813
, pp. 448-455
-
-
Lee, K.M.1
Jo, S.2
Kim, H.3
Lee, J.4
Park, C.S.5
-
15
-
-
77949350034
-
Identification of a primary target of thalidomide teratogenicity
-
Ito T., Ando H., Suzuki T., Ogura T., Hotta K., Imamura Y., Yamaguchi Y., Handa H. Identification of a primary target of thalidomide teratogenicity. Science 2010, 327:1345-1350.
-
(2010)
Science
, vol.327
, pp. 1345-1350
-
-
Ito, T.1
Ando, H.2
Suzuki, T.3
Ogura, T.4
Hotta, K.5
Imamura, Y.6
Yamaguchi, Y.7
Handa, H.8
-
16
-
-
84878257427
-
Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice
-
Lee K.M., Yang S.J., Kim Y.D., Choi Y.D., Nam J.H., Choi C.S., Choi H.S., Park C.S. Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice. Diabetes 2013, 62:1855-1864.
-
(2013)
Diabetes
, vol.62
, pp. 1855-1864
-
-
Lee, K.M.1
Yang, S.J.2
Kim, Y.D.3
Choi, Y.D.4
Nam, J.H.5
Choi, C.S.6
Choi, H.S.7
Park, C.S.8
-
17
-
-
84879621442
-
AMPK, insulin resistance, and the metabolic syndrome
-
Ruderman N.B., Carling D., Prentki M., Cacicedo J.M. AMPK, insulin resistance, and the metabolic syndrome. J. Clin. Invest. 2013, 123:2764-2772.
-
(2013)
J. Clin. Invest.
, vol.123
, pp. 2764-2772
-
-
Ruderman, N.B.1
Carling, D.2
Prentki, M.3
Cacicedo, J.M.4
-
18
-
-
65349177200
-
AMPK: an emerging drug target for diabetes and the metabolic syndrome
-
Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009, 9:407-416.
-
(2009)
Cell Metab.
, vol.9
, pp. 407-416
-
-
Zhang, B.B.1
Zhou, G.2
Li, C.3
-
20
-
-
84878759800
-
Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol
-
Kim D.K., Kim Y.H., Jang H.H., Park J., Kim J.R., Koh M., Jeong W.I., Koo S.H., Park T.S., Yun C.H., Park S.B., Chiang J.Y., Lee C.H., Choi H.S. Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol. Gut 2013, 62:1044-1054.
-
(2013)
Gut
, vol.62
, pp. 1044-1054
-
-
Kim, D.K.1
Kim, Y.H.2
Jang, H.H.3
Park, J.4
Kim, J.R.5
Koh, M.6
Jeong, W.I.7
Koo, S.H.8
Park, T.S.9
Yun, C.H.10
Park, S.B.11
Chiang, J.Y.12
Lee, C.H.13
Choi, H.S.14
-
21
-
-
84879104840
-
Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes
-
Jeong Y.T., Kim Y.D., Jung Y.M., Park D.C., Lee D.S., Ku S.K., Li X., Lu Y., Chao G.H., Kim K.J., Lee J.Y., Baek M.C., Kang W., Hwang S.L., Chang H.W. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes. Mol. Pharmacol. 2013, 84:147-157.
-
(2013)
Mol. Pharmacol.
, vol.84
, pp. 147-157
-
-
Jeong, Y.T.1
Kim, Y.D.2
Jung, Y.M.3
Park, D.C.4
Lee, D.S.5
Ku, S.K.6
Li, X.7
Lu, Y.8
Chao, G.H.9
Kim, K.J.10
Lee, J.Y.11
Baek, M.C.12
Kang, W.13
Hwang, S.L.14
Chang, H.W.15
-
22
-
-
84878806915
-
CAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis
-
Min A.K., Jeong J.Y., Go Y., Choi Y.K., Kim Y.D., Lee I.K., Park K.G. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis. Diabetologia 2013, 56:412-422.
-
(2013)
Diabetologia
, vol.56
, pp. 412-422
-
-
Min, A.K.1
Jeong, J.Y.2
Go, Y.3
Choi, Y.K.4
Kim, Y.D.5
Lee, I.K.6
Park, K.G.7
-
23
-
-
84862817442
-
Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models
-
Kim Y.D., Kim Y.H., Cho Y.M., Kim D.K., Ahn S.W., Lee J.M., Chanda D., Shong M., Lee C.H., Choi H.S. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models. Diabetologia 2012, 55:1482-1494.
-
(2012)
Diabetologia
, vol.55
, pp. 1482-1494
-
-
Kim, Y.D.1
Kim, Y.H.2
Cho, Y.M.3
Kim, D.K.4
Ahn, S.W.5
Lee, J.M.6
Chanda, D.7
Shong, M.8
Lee, C.H.9
Choi, H.S.10
-
24
-
-
77956262273
-
Induction of cereblon by NF-E2-related factor 2 in neuroblastoma cells exposed to hypoxia-reoxygenation
-
Lee K.J., Lee K.M., Jo S., Kang K.W., Park C.S. Induction of cereblon by NF-E2-related factor 2 in neuroblastoma cells exposed to hypoxia-reoxygenation. Biochem. Biophys. Res. Commun. 2010, 399:711-715.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.399
, pp. 711-715
-
-
Lee, K.J.1
Lee, K.M.2
Jo, S.3
Kang, K.W.4
Park, C.S.5
-
25
-
-
78651399025
-
Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db mice
-
Im S.S., Kim M.Y., Kwon S.K., Kim T.H., Bae J.S., Kim H., Kim K.S., Oh G.T., Ahn Y.H. Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db mice. J. Biol. Chem. 2011, 286:1157-1164.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 1157-1164
-
-
Im, S.S.1
Kim, M.Y.2
Kwon, S.K.3
Kim, T.H.4
Bae, J.S.5
Kim, H.6
Kim, K.S.7
Oh, G.T.8
Ahn, Y.H.9
-
26
-
-
64549119693
-
Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase
-
Liangpunsakul S., Wou S.E., Wineinger K.D., Zeng Y., Cyganek I., Jayaram H.N., Crabb D.W. Effects of WY-14,643 on the phosphorylation and activation of AMP-dependent protein kinase. Arch. Biochem. Biophys. 2009, 485:10-15.
-
(2009)
Arch. Biochem. Biophys.
, vol.485
, pp. 10-15
-
-
Liangpunsakul, S.1
Wou, S.E.2
Wineinger, K.D.3
Zeng, Y.4
Cyganek, I.5
Jayaram, H.N.6
Crabb, D.W.7
-
27
-
-
75149117805
-
Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1
-
Yamada E., Pessin J.E., Kurland I.J., Schwartz G.J., Bastie C.C. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metab. 2010, 11:113-124.
-
(2010)
Cell Metab.
, vol.11
, pp. 113-124
-
-
Yamada, E.1
Pessin, J.E.2
Kurland, I.J.3
Schwartz, G.J.4
Bastie, C.C.5
-
28
-
-
70449365855
-
Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?
-
Vatish M., Yamada E., Pessin J.E., Bastie C.C. Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?. Arch. Physiol. Biochem. 2009, 115:191-198.
-
(2009)
Arch. Physiol. Biochem.
, vol.115
, pp. 191-198
-
-
Vatish, M.1
Yamada, E.2
Pessin, J.E.3
Bastie, C.C.4
-
29
-
-
79959932859
-
P59fyn is associated with the development of hepatic steatosis due to chronic ethanol consumption
-
Fukunishi S., Tsuda Y., Takeshita A., Fukui H., Miyaji K., Fukuda A., Higuchi K. p59fyn is associated with the development of hepatic steatosis due to chronic ethanol consumption. J. Clin. Biochem. Nutr. 2011, 49:20-24.
-
(2011)
J. Clin. Biochem. Nutr.
, vol.49
, pp. 20-24
-
-
Fukunishi, S.1
Tsuda, Y.2
Takeshita, A.3
Fukui, H.4
Miyaji, K.5
Fukuda, A.6
Higuchi, K.7
-
30
-
-
77249094005
-
Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice
-
Shen Z., Liang X., Rogers C.Q., Rideout D., You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver. Physiol. 2010, 298:G364-G374.
-
(2010)
Am. J. Physiol. Gastrointest. Liver. Physiol.
, vol.298
, pp. G364-G374
-
-
Shen, Z.1
Liang, X.2
Rogers, C.Q.3
Rideout, D.4
You, M.5
-
31
-
-
57349114641
-
Resveratrol alleviates alcoholic fatty liver in mice
-
Ajmo J.M., Liang X., Rogers C.Q., Pennock B., You M. Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver. Physiol. 2008, 295:G833-G842.
-
(2008)
Am. J. Physiol. Gastrointest. Liver. Physiol.
, vol.295
, pp. G833-G842
-
-
Ajmo, J.M.1
Liang, X.2
Rogers, C.Q.3
Pennock, B.4
You, M.5
-
32
-
-
84894348922
-
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver
-
Yin H., Hu M., Liang X., Ajmo J.M., Li X., Bataller R., Odena G., Stevens S.M., You M. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology 2014, 146:801-811.
-
(2014)
Gastroenterology
, vol.146
, pp. 801-811
-
-
Yin, H.1
Hu, M.2
Liang, X.3
Ajmo, J.M.4
Li, X.5
Bataller, R.6
Odena, G.7
Stevens, S.M.8
You, M.9
-
33
-
-
84877956229
-
Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2
-
Yang C.S., Yuk J.M., Kim J.J., Hwang J.H., Lee C.H., Kim J.M., Oh G.T., Choi H.S., Jo E.K. Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2. PLoS One 2013, 8.
-
(2013)
PLoS One
, vol.8
-
-
Yang, C.S.1
Yuk, J.M.2
Kim, J.J.3
Hwang, J.H.4
Lee, C.H.5
Kim, J.M.6
Oh, G.T.7
Choi, H.S.8
Jo, E.K.9
-
34
-
-
61449106744
-
AMPK and the biochemistry of exercise: implications for human and disease
-
Richter E.A., Ruderman N.B. AMPK and the biochemistry of exercise: implications for human and disease. Biochem. J. 2009, 418:261-275.
-
(2009)
Biochem. J.
, vol.418
, pp. 261-275
-
-
Richter, E.A.1
Ruderman, N.B.2
-
35
-
-
78349283454
-
Peroxisome proliferator-activated receptor alpha target genes
-
Rakhshandehroo M., Knoch B., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010, 2010:1-20.
-
(2010)
PPAR Res.
, vol.2010
, pp. 1-20
-
-
Rakhshandehroo, M.1
Knoch, B.2
Müller, M.3
Kersten, S.4
-
36
-
-
0035823551
-
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta
-
Gervois P., Vu-Dac N., Kleemann R., Kockx M., Dubois G., Laine B., Kosykh V., Fruchart J.C., Kooistra T., Staels B. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J. Biol. Chem. 2011, 276:33471-33477.
-
(2011)
J. Biol. Chem.
, vol.276
, pp. 33471-33477
-
-
Gervois, P.1
Vu-Dac, N.2
Kleemann, R.3
Kockx, M.4
Dubois, G.5
Laine, B.6
Kosykh, V.7
Fruchart, J.C.8
Kooistra, T.9
Staels, B.10
-
37
-
-
0032565868
-
Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators
-
Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., Delerive P., Fadel A., Chinetti G., Fruchart J.C., Najib J., Maclouf J., Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 1998, 393:790-793.
-
(1998)
Nature
, vol.393
, pp. 790-793
-
-
Staels, B.1
Koenig, W.2
Habib, A.3
Merval, R.4
Lebret, M.5
Torra, I.P.6
Delerive, P.7
Fadel, A.8
Chinetti, G.9
Fruchart, J.C.10
Najib, J.11
Maclouf, J.12
Tedgui, A.13
-
38
-
-
0033527569
-
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
-
Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., Fruchart J.C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 1999, 274:32048-32054.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 32048-32054
-
-
Delerive, P.1
De Bosscher, K.2
Besnard, S.3
Vanden Berghe, W.4
Peters, J.M.5
Gonzalez, F.J.6
Fruchart, J.C.7
Tedgui, A.8
Haegeman, G.9
Staels, B.10
|